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Research Paper
Care coordination in a business-to-
business and a business-to-consumer
model for telemonitoring patients with
chronic diseases
Andrija S Grustam1,4, Hubertus Vrijhoef2, Antonio Cordella3,
Ron Koymans4 and Johan L Severens1
Abstract
Introduction: For telemonitoring to support care coordination, a sound business model is conditional. The aim of this
study is to explore the systemic and economic differences in care coordination via business-to-business and business-to-
consumer models for telemonitoring patients with chronic diseases.
Methods: We performed a literature search in order to design the business-to-business and business-to-consumer
telemonitoring models, and to assess the design elements and themes by applying the activity system theory, and
describe the transaction costs in each model. The design elements are content, structure, and governance, while the
design themes are novelty, lock-in, complementarities, and efficiency. In the transaction cost analysis, we looked into all
the elements of a transaction in both models.
Results: Care coordination in the business-to-business model is designed to be organized between the places of activity,
rather than the participants in the activity. The design of the business-to-business model creates a firm lock-in but for a
limited time. In the business-to-consumer model, the interdependencies are to be found between the persons in the
care process and not between the places of care. The differences between the models were found in both the design
elements and the design themes.
Discussion: Care coordination in the business-to-business and business-to-consumer models for telemonitoring
chronic diseases differs in principle in terms of design elements and design themes. Based on the theoretical models,
the transaction costs could potentially be lower in the business-to-consumer model than in the business-to-business,
which could be a promoting economic principle for the implementation of telemonitoring.
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Case management, chronic disease, costs, telemedicine, commerce
Introduction
Telemedicine and telemonitoring systems have pro-
foundly changed the way in which care is provided to
patients with chronic diseases. The value that different
telemedicine and telemonitoring systems can deliver is
closely related to a business model, which structures the
provision of the care service mediated by the techno-
logical architectures. Given that chronic diseases are
the main cause of disability and loss of quality of life
in the 21st century—where ischemic heart disease, cere-
brovascular disease, lower respiratory infections, lower
back and neck pain, and chronic obstructive pulmo-
nary disease are responsible for the biggest burden of
disease globally1—it is important to properly assess
how different telemedicine and telemonitoring business
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models impact upon healthcare provision where chron-
ic diseases are concerned. This is even more relevant
since chronic diseases are no longer seen as diseases of
affluence or diseases of the elderly. They are becoming
more prevalent in developing countries and among the
working population2 and will be the major reason for
the loss of public good in this century.3
So far health technology assessment efforts have
focused on cost-effectiveness of telemedicine, overlook-
ing the business model and stakeholder dynamic in
chronic disease management. The cost analyses have
not gone further than identification of utilization
from the payer or societal perspective, completely
ignoring the transaction costs in an implementation
model. Care coordination via telemedicine is intimately
tied to a business model which promotes or hinders
wider implementation via interdependencies of the
activity system. There is, therefore, a global need for
an effective and efficient way to organize activities
around the management of people who are at risk or
have been diagnosed with a chronic disease.
Chronic disease management and care coordination
The current care provision is inadequate to address the
challenges of an aging population.4 Chronic disease
management has proposed new concepts of care coor-
dination and integration as strategies for dealing in a
more efficient and cost-effective manner with the com-
plexity of chronic diseases and multimorbidity.5
Chronic disease management provides managerial sol-
utions to organize and coordinate the different com-
ponents involved in the care of chronic disease patients
pursuing a patient-centric approach.5 To achieve these
goals, and to ensure continuity of care and coordina-
tion between different healthcare services providers, an
integrated care approach is needed.6 Given the diversi-
ty and complexity of the activities involved in chronic
disease care provision, many different care coordina-
tion solutions have been proposed.
Schultz and McDonald7 identified 57 different defini-
tions of care coordination, distilling them into coordina-
tion efforts aiming at organizing patient care activities
between two or more participants (including the patient)
in order to support and enhance the delivery of the appro-
priate healthcare services; and into the coordination of
information exchanges among healthcare personnel, and
all the other resources required to deliver the expected
care services. The coordination logics underpinning the
two major clusters identified by Schultz and McDonald
in the analysis of key concepts of care coordination clear-
ly differ. However, they do overlap and have unclear
boundaries, and are used interchangeably8 when the
design and management of new coordination mecha-
nisms is undertaken. This is also evident in the design
of telemedicine and telemonitoring systems aiming at
supporting chronic care provision.
Telemonitoring, business models, and costs
Telemedicine and telemonitoring are often referred to
as “solutions” for delivering high-value care to a
patient with a particular condition, in a particular loca-
tion. Sood et al.9 analyzed 104 peer-reviewed defini-
tions of telemedicine, distilling them into an e-health
branch of services for delivery of healthcare and edu-
cation from one geographical location to another. The
World Health Organization10 provides a more compre-
hensive definition of telemedicine as
the delivery of healthcare service, where distance is a
critical factor, by all healthcare professionals using
information and communication technologies for the
exchange of valid information for diagnosis, treatment
and prevention of disease and injuries, research and
evaluation, and for the continuing education of health-
care providers, all in the interest of advancing the
health of individuals and their communities.
Home telemonitoring, a part of telemedicine, in turn is
defined as an automated transmission of patient’s
health status data from a home to the respective health-
care setting.11
Telemedicine and telemonitoring can therefore offer
great support for the provision of effective healthcare
services, minimizing the costs of the services in many
different configuration of healthcare and optimizing
the use of the resources needed to provide these serv-
ices. The successful implementation of telemedicine and
telemonitoring is challenging since it is not easy to
overcome the misfit between the patient’s needs and
the care model in place, which hampers the effective
deployment of these healthcare solutions in the first
place. Moreover, the different value chain configura-
tions of the business models used to support telemedi-
cine and telemonitoring solutions affect the value
generated by the chosen solution.12
A widely used definition of a business model by
Chesbrough and Rosenbloom13 is “a blueprint for
how a network of organizations cooperates in creating
and capturing value from technological innovation.”
Zott and Amit14 argued that the business model also
introduces the company’s bargaining power, i.e. the
ability to negotiate the price and the value it can
derive from its activity.
Telemonitoring is predominantly introduced via the
business-to-business (B2B) model.15 B2B is a strategy
where one business makes a commercial transaction
with another, e.g. a telemonitoring equipment manu-
facturer with a hospital. In many instances, B2B
136 International Journal of Care Coordination 20(4)
telemonitoring has not gone further than the pilot test-
ing,16 possibly due to reimbursement strategies, imple-
mentation issues, and/or economic principles. In the
B2B model, the technical and legislative costs prevent
the implementation of a full-scale long-term project
due to high transaction costs.17 Transaction costs are
costs incurred in the selling and buying process. They
are divided into search and information costs, bargain-
ing and decision costs, and policing and enforcement
costs.18 Different business models differ in terms of the
transaction costs generated for the agents of exchange,
and implementation is only possible when investment
does not exceed the costs incurred. Hence, new business
models for implementation of telemedicine and telemo-
nitoring in the management of chronic diseases should
be considered.
The alternative to the B2B model is the business-to-
consumer (B2C) model. B2C is a strategy where a busi-
ness makes a commercial transaction with the end cus-
tomer, e.g. a telemonitoring center with a patient. The
activities performed in the B2C model for telemonitor-
ing patients with chronic diseases are different, as are the
stakeholders, the structure, and the governance. The
new model allows care to be administered to patients
whenever and wherever they need it. It remains to be
seen to what extent the B2C model has an effect on the
transaction costs. A business model which leverages the
supply chain of healthcare services but lowers the trans-
action costs in the exchange in the healthcaremarket has
yet to be found.17
Theoretical framework
An activity system describes the set of activities that a
company performs in order to capture value and is
characterized by interdependencies between its suppli-
ers and customers.14 An activity of a company can
be explained as “the engagement of human, physical
and/or capital resources of any party to a business
model (the focal firm, end customers, vendors, etc.)
to serve a specific purpose toward the fulfillment of
the overall objective.”14
We employ the activity theory19 to assess the design
elements and the design themes in telemonitoring
patients with chronic diseases via “the NICE
model.”14 The NICE model suggests that the value gen-
erated by an activity system is characterized by different
design themes that consist of alternative configuration
of systems’ design elements. The design elements of an
activity system consist of content, structure, and gover-
nance. The design themes are novelty, lock-in, comple-
mentarities, and efficiency. These two sets of design
parameters capture the purposeful, firm-centric design
of the activity systems.14 The framework provides
an insight by (a) giving business model design a
language, concepts, and tools; (b) highlighting business
model design as a key managerial/entrepreneurial task;
and (c) emphasizing system-level design over partial
optimization.14
The central concept of the activity system theory is
interdependencies, which provide insights into processes
that enable a company’s activities to evolve, even if the
market in which the company is competing changes.20
The interdependencies across activities are chosen by
managers in order to better position and integrate a
company in the environment in which it operates.
The architecture of the activity system defines the pos-
sible interactions between the suppliers, the company,
and the customers and is the source of the competitive
advantage in the ecosystem in which it operates.
The activity system cannot easily be changed without
repercussions on the interdependencies created. Such
an architecture, i.e. a network, is in fact a business
model.21
Complementary to the activity system theory is the
transaction costs theory.22 Transaction costs theory
looks into the efficiency dimension of an exchange pro-
cess. The theory claims that different factors (uncer-
tainty, bounded rationality, opportunistic behavior,
and small numbers) impact upon the way in which
organizations coordinate exchanges and indeed activi-
ties. These costs unfold in three different phases of an
exchange: search, negotiation, and enforcement.23 The
phases of the transaction unfold as activities in the
activity theory.
The analysis of the impact of transaction costs on
the activities underpinning telemonitoring in the B2B
setting, currently predominant in telemonitoring imple-
mentation, and in the B2C, was chosen to compare the
effectiveness of the two different business models.
There are several cycles of activities that add up to
the transaction costs total24:
1. Search costs—incurred when agents spend time
looking for opportunities for an exchange (in the
healthcare domain the exchange of a healthcare
service/product for money);
2. Negotiation costs—the costs associated with negoti-
ating the terms of this exchange;
3. Enforcement costs—the costs associated with
enforcing the agreement to exchange.
Transaction costs are seen as the costs incurred by
running imperfect systems.25 The elementary unit of
analysis in this theory is the exchange between at
least two individuals.24 If all participants in an econom-
ic exchange were to have the same information, the
transaction costs would be nonexistent. Healthcare is
full of these kinds of imperfections because the knowl-
edge is protected by the people who have it, either by
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means of a license to practice or a license to establish a
practice.
Activity theory is potentially useful in portraying the
interdependences in different telemonitoring systems.
The transaction costs analysis of those interdepend-
ences might allow identification of the most efficient
and effective telemonitoring configurations, and help
mangers and engineers to design more efficient and
effective chronic care solutions.
Study aim
The aim of this study is, first, to create the B2B and
B2C care models and, second, to explore the differences
in care coordination and transaction costs between
these models for telemonitoring patients with chronic
diseases. Our hypothesis is that, due to the different
activity systems, the transaction costs in the B2C
model for telemonitoring chronic diseases are lower
than in the B2B model. The transaction costs are
taken as a proxy for model efficiency.
Methods
We performed a literature synthesis in order to inform
the B2B and B2C telemonitoring case creation, to
assess the design elements and themes by applying the
activity system theory, and to estimate the transactions
costs in each case.
Literature search and analysis
The literature synthesis was performed via Google
Scholar, where papers in English from 2000 onward
were retrieved. We searched for the following terms
(in various combinations): B2B, B2C, case, model,
design, telemonitoring, telemedicine, telehealth. We
opted for a convenience sample26 without exclusion
criterion. We looked for case studies and conference
papers with design elements of telemonitoring systems,
in order to design our own. The input was interpreted
in the B2B and B2C model for telemonitoring. As such,
the literature analysis can be described as a directed
content analysis approach.27 The literature was searched
for and gathered by the first author, while all authors
were involved in the analysis.
Cases creation
We created two telemonitoring cases for two business
models—B2B and B2C—involving all the actors iden-
tified by the literature search. We also incorporated the
design elements found in the literature—monitoring,
modules, mediators, and actors–devices relationships.
Then we applied the research design approach pro-
posed by Griffioen.28 Griffioen used the activity
system theory in the sustainable business model
design for heart failure home telemonitoring opportu-
nities in Western Europe and created a transaction
mapping tool to communicate roles and transaction
relations. We created a similar map, with a set of
actors and a relational context looking at modules
and relationships in B2B and B2C model of telemoni-
toring. Individuals (actors) are represented by a circle
(patient, informal caregiver, care coordinator, social
worker, registered nurse, physician, pharmacist, and tel-
enurse) while institutions (stages) are represented by
squares (home, hospital, pharmacy, and telemonitoring
center). The relations are described in terms of voice,
data, money, and drug exchange. The activity system
mapping was followed by the transaction costs explora-
tion for both models, B2B and B2C, and the discussion
on the impact of the business model on the implemen-
tation possibilities of the two alternative applications.
Results
Literature review inputs
In total 22 papers were retrieved by the literature
search. Seven papers were included in the analysis
(three conference papers, two case studies, and two
journal articles) while others were omitted as they did
not contain useful design elements. The diagrams from
the publications that were included were used to create
the B2B and B2C telemonitoring cases.
The main finding from this limited number of sour-
ces was that companies are developing new markets
through the B2C models,29 while in the B2B models
they are trying to replicate and support the existing
organizational structure.30 From the eICU case,31 we
replicated the remote monitoring part, both in the B2B
and B2C setting, while from the mobile multimedia
medical system design and implementation case32 we
considered four modules necessary for system to oper-
ate: information desk, patient’s portal, video outpatient
service, and electronic medical information module.
From the document-based service platform for telemed-
icine,33 we replicated the “mediator” which in our ver-
sion of the B2C case is a Telemonitoring Center. From
the telemedicine market case34 we considered the actors–
devices relationship, and from the COPD24 case35 archi-
tectures of the business cases, i.e. the B2B and B2C case.
The literature inputs to the B2B and B2C telemonitoring
cases are presented in Table 1.
Telemonitoring cases
In the B2B model (Figure 1) ICT is used for commu-
nication between the patient and the telehealth team,
which consists of a care coordinator, a physician,
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Table 1. Literature inputs to the telemonitoring cases.
Author(s) Year
Type of
study design Study objective Main findings
Herzlinger
et al.31
2014 Case Study “Would the advent of global payment
models and ACOs create sufficient
demand for a telemedicine offering
covering the care continuum, from
hospitals to the home? This was the
decision facing Royal Philips
Electronics (Philips), the
Netherlands-based producer of
lighting, consumer electronics, and
health care products, in 2012.”
“In the eICU model, patients in hospital ICUs were
monitored using bedside devices, which transmit-
ted patient data to a remote station from which
clinicians monitored and directed care as needed.
The model aimed to improve care quality by
enabling early interventions and reducing adverse
events, and to cut costs by allowing clinicians to
care for a larger number of patients. Building on
this and other offerings in its portfolio, including
numerous home care devices, Philips could extend
this model to create an integrated remote moni-
toring offering managed through a centralized cli-
nician-staffed station.”
Kung et al.32 2006 Qualitative
Research
“This study describes in detail the
system design principles and imple-
mentation considerations for mobile
telemedicine systems. The system
effectiveness and limitations for
practical system deployment and
usage are described based on the
technical and managerial analysis.”
“The M3 system can also be used in a hospital’s B2B
or B2C’s customer relationship management
frameworks. A hospital can trace the patient’s
situation online at any time, and provide informa-
tion on healthcare to the patient (B2C) as well as
share information and experience with other
hospitals (B2B). This approach can improve the
quality of the medical treatment given by a hospital
and its medical professionals, and thus increase the
loyalty of a patient to the hospital.”
L€ahteenm€aki
et al.33
2008 Conference
Paper
“In this paper, we present a generic
service platform, which is applicable
in a wide range of telemedicine
applications and in other areas
involving the need for confidential
information exchange.”
“The pilot hosted by the Tampere Heart Centre
showed that a cardiac consultation service is
useful even without full integration with the EPR.
Both the Heart Centre cardiologists and the
physicians of the remote units considered the
benefits of the consultation service to be high. In
the consultation cases, cardiology diagnostics and
medication could be refined and guidance for
patient logistics was provided. The physicians
considered it feasible to use a commercial con-
sultation service when available.
Pels et al.34 2011 Case Study “BioScience (BS) is an Argentine com-
pany, which develops and commerci-
alizes innovative diagnosis equipment
since 1995. The BM is a device which
sends vital signals (from a patient
with a chronic disease) through the
mobile phone to a recipient’s cell
phone (doctor and/or relative).Three
market segments, the alternative
value propositions and the suggested
go-to-markets for each of them are
suggested.”
“BS realized that contrary to the neurological
market, where it was crucial to be in a clinical
network, in the telemedicine market, it was fun-
damental to be associated with telecommunica-
tion companies. BS needed the telcos as they had
the infrastructure necessary to offer the service.
Alternatively, telcos saw telemedicine as an addi-
tional high-value application they could offer. BS
had already signed an alliance with Telefonica
Argentina. The agreement followed the industry
practice (such as ringtones) in which the 30 per
cent of the profit would go to BS, and the 70 per
cent remaining to Telefonica Argentina.”
Shevchenko30 2004 Qualitative
Research
“The goal of this paper is to outline
important trend(s) in the advance-
ment of this rapidly growing area of
economy, i.e. the transformation of
e-market, and to provide recom-
mendations regarding feasible struc-
ture of emerging integrated industrial
production/distribution chains, which
could be useful for businesses.
“Like e-market place, i.e. B2C eHub, which has its
conventional analogue in supermarket, the B2B
eHub can be considered as web-based extension
of a conventional enterprise, namely as a sort of
‘virtual’ implementation of a large corporation
with specialized departments spread over the
territory, e.g. city, region or country.”
(continued)
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a social worker, a pharmacist, and a registered nurse—
all based in a hospital. This model of healthcare deliv-
ery is also referred to as “hospital-to-home” telemedi-
cine.31 During the multidisciplinary rounds, each
patient is assessed according to their physiological
signals, which are transmitted by the telemonitoring
devices, and according to their personal goals/
motivation. Via interactive dashboards, the team can
easily spot a patient whose condition is deteriorating
and who therefore needs more help. They help dis-
charged patients by caring for them in an outpatient
setting via technology. In the B2B operation this is
usually via some sort of eHub—“a virtual implementa-
tion by a large corporation with specialized depart-
ments spread over the territory, e.g. city, region or
country.”30
In the B2C model (Figure 2) the communication
takes place between a telemonitoring nurse, based on
a telemonitoring center (in our design), and the rest of
the stakeholders (including the patient) in their respec-
tive organizations.29 The telemonitoring nurse moni-
tors the physiological data daily, aided by smart
algorithms. This nurse places a call to the patient
every fortnight in order to assess their therapy adher-
ence, emotional state and—if the patient is chronically
ill—their wellbeing. Telenurses act as healthcare navi-
gators, helping patients with the complexities of both
the healthcare system and the disease and, as personal
health coaches, they provide a helping hand to patients
and informal caregivers. In this respect, the B2C model
is a mixture of a high-touch and high-tech approach in
chronic disease management. The dashed lines in
Figure 2 represent possible scenarios that go beyond
the one we created for the purpose of this assessment:
(1) a reimbursement by government/insurer to a patient
directly, (2) a payment by government/insurer to tele-
monitoring center for a cohort of patients, and (3) a
payment by informal caregiver to telemonitoring
center. In the literature, we also found scenarios
where drugs are sent from a pharmacy to a patient
via post.
In the cases, we designed monitoring (in both the
B2B and the B2C model) to take place via a smart-
phone connected to an array of devices, depending
on the severity of the disease (blood pressure meter,
weighing scale, medication dispenser, etc.). The patient
Table 1. Continued
Author(s) Year
Type of
study design Study objective Main findings
Wac and
Hausheer35
2011 Conference
Paper
“The goal of our COPD24 scenario is
to demonstrate and validate the
precise conditions to be fulfilled from
a healthcare perspective, as well as
derive requirements for Future
Internet (PI) technologies for subse-
quent deployment of self-manage-
ment and tele-monitoring/treatment
services for COPD patients.”
“Two main alternatives can be distinguished in terms
of potential business cases for the COPD24 ser-
vice. The COPD patient can either have a
Business-to-Consumer (B2C) relationship directly
with the COPD24 application provider, or with
the mobile network operator. In the former case,
the COPD24 application provider takes care of
establishing SLAs with all involved mobile network
operators, denoted as Business-to-Business (B2B)
relationships. Optionally, a user may have an
additional business relationship with its (home)
mobile network operator. In the latter case, the
mobile network operator is the only entity in B2C
relation with the patient, while the mobile net-
work operator’s B2B relationship with COPD24
application provider is transparent to the patient.”
Wen and
Tan29
2003 Conference
Paper
“More specifically, hospitals and health
provider organizations tend to use
static websites that supply informa-
tion, but have not made major
investments in interactive technolo-
gies to engage patients and health-
care consumers more actively. In this
paper, we survey a number of key
participants in the e-health market-
place and the technologies that these
players have employed to date.”
“Pharmaceutical companies are developing new
markets through B2C e-commerce sites. Vendors
such as Merck are also able to reduce their mar-
keting costs by reaching more consumers (both
patients and physicians) for less cost with e-health
offerings. The third approach is remote medical
management via the telephone or electronic
communication. Chronic disease is particularly
suitable for remote management, especially when
there is continuity between the patient and service
provider.”
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either has a direct relationship with the telehealth
provider or with a hospital/service network/care
organization.35 The telemonitoring team uses the care
coordination tool (i.e. a series of interactive dashboards
that unify the signals and readings from different
patients) connected to a document-based service
platform (i.e. electronic patient record) to follow the
progress of the disease.33 A telemonitoring platform
allows the team to analyze the root cause of the events
(e.g. hospitalization) in order to prevent or avoid them,
and to amend therapy. The outcomes are constantly
measured and reassessed for both the patients and the
program. The gathering of the data is unobtrusive and
continuous, i.e. runs in the background of the care coor-
dination processes. All the participants in the care pro-
cess have access to the monitoring data and the disease
progression charts. Patients can follow an exercise pro-
gram with remote monitoring and coaching via a mobile
multimedia medical system.32
Customization of the telemonitoring service, via
smart algorithms using educational content, surveys,
information provision, games, etc., is a crucial part of
the value creation in the B2C approach. The value
proposition in this case is delivered via telecom oper-
ators. Value in the B2C model is captured by cost and
risk reduction, and increase in convenience and usabil-
ity. It has a similar proposition to B2B, where
customers essentially buy “peace of mind,” but with
more convenience as the service runs on a personal
device and is considered “device-agnostic.”
Care coordination in B2B and B2C telemonitoring
The care coordination in the B2B case (Figure 1) is
organized between the places of activity, rather than
between the participants in the activity. The activity
performed via voice communication is intermittent
patient support, while the data gathering and analysis
runs continuously in the background. The telehealth
team meets in a physical location (i.e. hospital) and
communicates with other physical locations (i.e.
home) where the other two participants are present—
the patient and the informal caregiver. The care coor-
dinators are needed in both physical locations—the
care coordinator in the hospital and the informal care-
giver in the home. This adds a layer of complexity to
the care process and subsequently increases costs. The
principal interdependencies in this activity system are
location based—all participants in the care process,
except the patient, are “exchangeable,” while the loca-
tions are “fixed.”
The care coordination in the B2C case (Figure 2) is
organized between the players in the activity system
and rarely between the places. The patient in this
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Figure 1. Individual and institutional communication in the B2B model for telemonitoring patients with chronic diseases.
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system is able to receive care on the move and at home.
In the B2C business model, a telemonitoring nurse is a
central character and, just like a personal health coach,
manages the players and the resources in the care con-
tinuum. This reduces costs as there is no need to coor-
dinate staff at both locations. The interdependencies lie
between the persons in the care process (the telenurse,
the informal caregiver, and the patients) and not
between the places of care. The institutional interde-
pendencies are digitized and automated—via data
transfer, digital prescriptions, and access to interactive
dashboards—which enables all players to have timely
and accurate information at hand.
Activity system and transaction costs
in B2B and B2C telemonitoring
The design elements and the design themes differ in the
B2B and the B2C activity system for telemonitoring
patients with chronic diseases. The content is the
same in both cases, but the structure (i.e. hospital
versus telemonitoring center) and the governance
differ. In the B2B case the hospital providing the ser-
vice is also responsible for the governance and opera-
tion of the service (together with the equipment
manufacturer), while in the B2C case the official gov-
erning body of the jurisdiction should be in charge (or,
in the absence of a competent body, an international
healthcare organization). This is necessary due to the
legal, ethical, and socioeconomic factors associated
with telecare.36 Thus, the novelty of the B2C case lies
in the structure and governance. Also, the customer
(i.e. patient) in the B2C case is not locked-in and can
opt out from the service at any time. This helps with the
continuity of the service. And, finally, the complemen-
tarities in the two cases differ. In the B2B case commu-
nity services (via the social worker and care
coordinator) generate value for the patient, while clin-
ical trials generate value for the hospitals and the
equipment manufacturer. In the B2C model there are
PhysicianSocial Worker
HOSPITAL
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HOME
Patient
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Figure 2. Individual and institutional communication in the B2C model for telemonitoring patients with chronic diseases.
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different complementarities, e.g. monitoring comorbid-
ities benefiting the patient, population monitoring
benefiting the government, and big data gathering
benefiting the equipment manufacturer. The design ele-
ments and themes of both the B2B and the B2C activity
system frameworks are presented in Table 2, where the
transaction costs are explored in the efficiency domain.
The transaction costs of the B2B case are relatively
high. Customers (patients) can spend considerable
time/resources in searching for the telemonitoring pro-
vider (via their physician) and understanding the
disease-related implications of the program. Patients
have to negotiate the eligibility in terms of the severity
of the disease, location, and ongoing costs.37 In the
end, patients need to enforce the contract either by
installing/deinstalling the equipment in their home or
by negotiating with the provider and insurance compa-
ny to keep it after the trial has ended.37
In the B2C case, the expected reduction in search
costs is due to easier access to information via the
Internet (or mass media), the reduction in negotiation
costs thanks to an app-store-based contract (predefined
and only “a click away”), and the reduction in
enforcement costs due to the ease of downloading the
mobile app and joining the service, or deleting it (i.e.
opting out). Patients can act freely in the marketplace
Table 2. Assessment of the B2B and B2C models for telemonitoring chronic diseases in the activity system design framework.
Design B2B B2C
Elements
Content What activities should be
performed?
Telemonitoring, education, and
patient support.
Telemonitoring, education, and patient
support.
Structure How should they be linked
and sequenced?
The care coordination takes
place between the telehealth
team in the hospital and the
team at home (i.e. between a
hospital and a home). The
team meets in a specific loca-
tion at a specific time, reviews
the patient’s data, and engages
in an audio/video conversation
with the patient and a per-
sonal health coach at home.
The care coordination takes place
between the members of the care
team (i.e. telemonitoring nurse,
informal caregiver, and patient) via
voice communication and with the
institutions it takes place via data
sharing (i.e. telemonitoring center,
hospital, and pharmacy). Voice com-
munication takes place every fort-
night while data are shared
continuously.
Governance Who should perform
them, and Where?
Hospital and technology partner
(i.e. equipment manufacturer).
The governance takes place in
a clinical setting by licensed
practitioners, while the equip-
ment manufacturer is respon-
sible for the system
maintenance and data
protection.
International and national governing
bodies. In a jurisdiction where a
government acts as an insurer it
should perform licensing and super-
vision. In other geographies an
international telehealth organization
should provide governance.
Themes
Novelty Adopt innovative content,
structure, or
governance
Innovative content, old struc-
ture, and governance.
Innovative content, structure, and
governance.
Lock-In Build in elements to retain
business model stake-
holders, e.g. customers
Customers/patients are locked in
by the installation of the
equipment in their home.
Customers/patients are not locked in
and can opt out of the service at any
time.
Complementarities Bundle activities to gener-
ate more value
Community services generate
value for the patient. Clinical
trials generate value for the
hospitals and the equipment
manufacturer.
Monitoring comorbidities generates
value for the patient. Population
monitoring generates value for the
government. Big data generate value
for the equipment manufacturer.
Efficiency Reorganize activities to
reduce transaction costs
High search, negotiation, and
enforcement costs.
Medium search costs, and low negotia-
tion and enforcement costs
B2B: business-to-business; B2C: business-to-consumer.
Source: Adapted from Zott and Amit.14
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because they are paying for the service, and this is pro-
moting consumer-driven services in healthcare.
The negotiating costs are virtually zero in the B2C
case, as they are with all app-based services and con-
tracts. The enforcement costs for telemonitoring chron-
ic diseases are also close to zero, as the B2C model of
digital service distribution puts the power into the
hands of consumers (i.e. they can opt out at any time).
Discussion
We explored the activity system in the B2B and B2C
telemonitoring applications for patients with chronic
diseases, with the aim of understanding the care coor-
dination and the economic principles that govern the
effectiveness in both business models. We believe there
are principal differences in several design elements
(structure and governance) and themes (novelty,
lock-in, complementarities, and efficiency), with lower
transaction costs in the B2C model due to the lower
search, negotiation, and enforcement costs. The busi-
ness models of B2B and B2C telemonitoring, and the
value propositions, are reviewed elsewhere in Chen
et al.12 and Acheampong and Vimarlund38 but the
activity systems are not.
In the B2B model the activity system is organized
around the places while the governance of the system
lies with hospitals (the true customers) and equipment
manufacturers. The B2C model revolves around the
players whose actions should be overseen by a govern-
ment or insurer. The asymmetry of information, the
structures, and the competences might give hospitals
power over other agents in the healthcare market,
namely patients (customers) and equipment manufac-
turers (suppliers). Patients have no say in procurement,
and thus the demand for the B2B telemonitoring
remains weak.
The B2B model creates a firmer lock-in than B2C,
but for a limited time (e.g. until supported by insurance
payments). On the other hand, patients can stay with
the B2C telemonitoring service while transitioning to
another healthcare provider/insurer, which ensures a
long-term commitment. The B2C model also allows
patients to procure the telemonitoring service at
market prices, assuring a more equitable healthcare
exchange.
There is some intrinsic uncertainty in relations
between the agents in the marketplace that exist for
long periods of time, such that agents in the exchange
can exhibit undesirable behavior, i.e. opportunistic
behavior.39 This opportunistic behavior means that
an agent acts in their own interest, at the expense of
all other agents.17 There are two applicable opportu-
nistic behaviors40: opportunism due to the fact that an
agent’s behavior is not visible, and opportunism due to
the specific nature of the assets. The former is applica-
ble to the B2C model (and can lead to moral hazard),
while the latter is applicable to the B2B model of tele-
monitoring (the asset cannot be easily redeployed, and
the participants in the exchange are bound to each
other). The need to protect the parties from opportu-
nistic behavior justifies the existence of governance
structures.41 Beside national and international govern-
ing bodies, markets and hierarchies are proposed as
alternative ways of governing these transactions.24
Pelletier-Fleury et al.17 used transaction cost eco-
nomics as a conceptual framework for the analysis of
barriers to the diffusion of telemedicine. They found
that “the introduction of telemedicine shifts the costs
associated with agents’ opportunism from patients to
healthcare suppliers themselves.”17 These costs prevent
the wider implementation of telemedicine and telemo-
nitoring. Pelletier-Fleury et al.17 provided a solution
for reducing the transaction costs associated with
behavioral factors (bounded rationality and opportun-
ism) and environmental factors (uncertainty and asset
specificity) by creating an institutional arrangement
associated with the healthcare transactions. Due to
the high specificity of the telemedicine asset, and insti-
tutional uncertainty, they advocate the integration of
transactions in a unified structure. We take their
research one step further, by applying the same reason-
ing for telemonitoring chronic diseases in the B2B case
(via hospitals), but also in the B2C case (via a telemo-
nitoring center).
From this theoretical exercise, it would appear that
the B2C model has advantages over the B2B model in
the implementation of telemonitoring, such as supply
chain optimization (with five instead of seven people
involved in care coordination), low negotiation and
enforcement costs, and long-term outlook. The com-
munication between players is expected to be more effi-
cient than between places. The patient is decoupled
from interactions with hospitals and pharmacies,
enabling healthcare services to be provided irrespective
of the location of the agents. This not only potentially
improves implementation of telemonitoring via the
B2C model but also ensures easier access to healthcare.
Transaction cost theory posits that “the optimum
organizational structure is one that achieves economic
efficiency by minimizing the costs of exchange.”42 The
costs are often a result of the imperfections in posses-
sion of information, by participants in the market,
and the value that agents place on the exchange. The
patient can be seen as an agent willing to invest in
resources to mitigate these imperfections. However,
the investment needed to do so is substantial, and in
many cases detrimental to the effort. This is certainly
true for the B2B model, where transaction costs are
high but might not be true for the B2C. Even if a
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patient makes a “wrong” decision and incurs switching
costs in the B2C model, they still might be smaller in
absolute terms than transaction costs of the B2B
model. This might be a promoting economic principle
for B2C telemonitoring.
North43 proposed a theoretical framework for the
measurement of transaction costs, i.e. the calculation
of the value of all aspects of the good or service
involved in a transaction. Measurement, being his
first factor in his take on transaction costs, is related
to his third, ideological attitudes and perceptions. They
encapsulate each individual’s set of values, which influ-
ence one’s interpretation of the world. In a B2C model,
consumers have to search and compare multiple sour-
ces of information, depending on how many suppliers
partake in the market, with unknown quality compared
to the information they receive from a provider such as
a hospital or physician in the B2B model. By eliciting
ideological values and perceptions, it is permissible that
a person will find more value or quality in information
given in the B2B model, via hospitals/physicians, than
in the B2C model. However, the ease of finding infor-
mation and the costs will remain the same, and they are
in our opinion lower in the B2C model. The value of
information, in respect to transaction costs but also
cost-effectiveness in B2B and B2C telemonitoring of
chronic diseases, is yet to be determined, and so is
the expected value of perfect information, i.e. the
price one should pay to get rid of uncertainty in one’s
decision making.44
Our analysis was not without limitations. The liter-
ature search was performed by one author (ASG) while
all authors were involved in the data analysis. For the
literature review, a convenience sample was used. The
creation of the telemonitoring cases was based on the
sample of peer-reviewed and non-peer-reviewed sour-
ces (journal articles, conference papers, and case stud-
ies). The assessment of the design elements and themes
of the activity system in both models was not impartial.
The same is true for the assessment of the transaction
costs in the efficiency domain. However, we believe
that, given the aim of this study, the strategy applied
was suitable to conceptually design the B2B and B2C
cases and to explore the potential value of two business
models in a descriptive and interpretative manner.
Future research should test our models, for example
by collecting empirical data from different sites where
telemonitoring is applied to support care coordination.
Telemonitoring is commonly introduced to chronic
disease patients via the B2B model and is implemented
via arrangements between equipment manufacturers
and care providers—homecare agencies, delivery sys-
tems, and health plans.45 This takes agency away
from patients and burdens them heavily with search,
negotiation, and enforcement costs. It renders the B2B
model inefficient in comparison to the B2C model,
because of the high exchange costs, which could
explain the anemic uptake of telemonitoring so far
and the suboptimal coordination of care.
The activity system perspective allowed us to see the
complexities of care coordination in chronic disease
management via innovation in the business model.
The transaction costs framework was a useful way of
considering the efficiency of introducing information
systems to healthcare. The B2B and B2C cases created
for telemonitoring chronic diseases principally differ in
design elements (structure and governance) and design
themes (novelty, lock-in, complementarities, and effi-
ciency). In the B2B model, we believe the search costs
are high, negotiation costs even higher (if possible), and
enforcement costs the highest. In the B2C model the
situations is completely the opposite—transaction costs
are small in search, smaller in negotiation, and virtually
zero in enforcement. Thus, implementation of telemo-
nitoring for chronic diseases via the B2C model can
potentially free up financial resources, which can
either be used to support a greater number of people
with the same technology or can be invested in new
treatments and therapies.
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